FDA-Approved CAR-T Therapies
In addition to the novel CAR-T therapies offered through our clinical trials program, our care team can provide our patients the following FDA-approved therapies:
Kymriah for acute lymphoblastic leukemia or non-Hodgkin lymphoma
Yescarta for large B-cell lymphoma and follicular lymphoma
Tecartus for mantle cell lymphoma and adult lymphoblastic leukemia
Breyanzi for large B-cell lymphoma
Abecma for relapsed or refractory multiple myeloma